U.S. Markets closed
  • S&P 500

    3,911.74
    +116.01 (+3.06%)
     
  • Dow 30

    31,500.68
    +823.32 (+2.68%)
     
  • Nasdaq

    11,607.62
    +375.43 (+3.34%)
     
  • Russell 2000

    1,765.74
    +54.06 (+3.16%)
     
  • Crude Oil

    107.06
    +2.79 (+2.68%)
     
  • Gold

    1,828.10
    -1.70 (-0.09%)
     
  • Silver

    21.13
    +0.09 (+0.42%)
     
  • EUR/USD

    1.0559
    +0.0034 (+0.3273%)
     
  • 10-Yr Bond

    3.1250
    +0.0570 (+1.86%)
     
  • Vix

    27.23
    -1.82 (-6.27%)
     
  • GBP/USD

    1.2270
    +0.0009 (+0.0736%)
     
  • USD/JPY

    135.2100
    +0.2770 (+0.2053%)
     
  • BTC-USD

    21,080.13
    +93.00 (+0.44%)
     
  • CMC Crypto 200

    462.12
    +8.22 (+1.81%)
     
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • Nikkei 225

    26,491.97
    +320.72 (+1.23%)
     

Accenture (ACN) Joins Health Data Collaborative, AI4BetterHearts

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Accenture plc ACN has joined AI4BetterHearts, a global data collaborative that uses artificial intelligence and advanced analytics to pool, mine and analyze heart health data to help patients, health workers, health system managers and policymakers improve decision making on heart health.

Accenture said that its goal behind joining the collaborative is to support and advance cardiovascular disease prevention through integrating innovation and emerging technologies.

Stuart Henderson, global Life Sciences lead for Accenture, noted, "By applying technology, we can develop data-driven insights on the true catalysts of health and equity and help drive informed decisions for policy change."

AI4BetterHearts was founded by Microsoft MSFT and the Novartis NVS Foundation, and is the first global data collaborative for improving cardiovascular health.

Microsoft focuses on enhancing data sharing and cross-border research collaboration using its Microsoft AI for Health initiative, Open Data Campaign and its focused AI work.

Novartis contributes data from its urban health initiative, Better Hearts Better Cities, in Latin America, Africa and Asia, and from other programs as well.

Zacks Rank and Price Performance

Accenture currently carries Zacks Rank #3 (Hold). Its shares have gained 21.2% over the past year, underperforming the 23.1% growth of the industry.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Accenture PLC Price

Accenture PLC Price
Accenture PLC Price

Accenture PLC price | Accenture PLC Quote

Microsoft also carries a Zacks Rank #3. The stock appreciated 24.3% over the past year, outperforming the 13.4% growth of the industry it belongs to.

Novartis carries a Zacks Rank #4 (Sell). Its shares have gained 0.5% over the past year compared with 26.7% growth of the industry.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Novartis AG (NVS) : Free Stock Analysis Report

Microsoft Corporation (MSFT) : Free Stock Analysis Report

Accenture PLC (ACN) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research